Iloprost therapy up to 2 ng/kg x min ( DrugBank: Iloprost )
1 disease
告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
51 | 全身性強皮症 | 1 |
51. 全身性強皮症
臨床試験数 : 523 / 薬物数 : 608 - (DrugBank : 156) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 215
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00622687 (ClinicalTrials.gov) | September 1997 | 14/2/2008 | Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis | Comparision Between Maximally Tolerated Intravenous Iloprost Doses Versus Low-Dosed Iloprost for a 21-Day Treatment Course | Systemic Sclerosis | Drug: iloprost;Drug: iloprost low dose;Drug: iloprost therapy up to 2 ng/kg x min | Charite University, Berlin, Germany | Schering-Plough | Terminated | 18 Years | 80 Years | Both | 50 | Phase 2 | Germany |